Cargando…

Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents

Detalles Bibliográficos
Autores principales:	Goel, Shipra, Segal, Brahm, Griffiths, Elizabeth A., Hernandez-Ilizaliturri, Francisco, Torka, Pallawi, Cortese, Matthew J, Ghione, Paola, Nemeth, Michael J., Muhitch, Jason
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology. Published by Elsevier Inc. 2022
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665258/ http://dx.doi.org/10.1182/blood-2022-170369

Ejemplares similares

Determinants of COVID-19 Vaccine Response in Patients with Lymphoma on B Cell Directed Therapy
por: Goel, Shipra, et al.
Publicado: (2021)

Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell–directed therapies
por: Ghione, Paola, et al.
Publicado: (2021)

Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphoma
por: Singh, Anil R., et al.
Publicado: (2020)

Pharmacologic targeting of Nedd8-activating enzyme reinvigorates T-cell responses in lymphoid neoplasia
por: Wang, Xiaoguang, et al.
Publicado: (2023)

Pevonedistat, a NEDD8‐activating enzyme inhibitor, induces apoptosis and augments efficacy of chemotherapy and small molecule inhibitors in pre‐clinical models of diffuse large B‐cell lymphoma
por: Torka, Pallawi, et al.
Publicado: (2020)

Mechanisms of lymphoid depletion in bowel obstruction
por: Lin, You-Min, et al.
Publicado: (2022)

Immune profiling in Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma Patients treated with Autologous Hematopoietic Cell Transplant
por: Herr, Megan M., et al.
Publicado: (2019)

Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCL
por: Torka, Pallawi, et al.
Publicado: (2022)

Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution
por: Griffiths, Elizabeth A., et al.
Publicado: (2021)

CD3-immunotoxin mediated depletion of T cells in lymphoid tissues of rhesus macaques
por: Wang, Lan, et al.
Publicado: (2023)

CAR T-cell therapy has comparable efficacy with autologous transplantation in older adults with DLBCL in partial response
por: Akhtar, Othman S., et al.
Publicado: (2023)

Cell adhesiveness is related to tumorigenicity in malignant lymphoid cells
Publicado: (1984)

Innate Lymphoid Cells in the Malignant Melanoma Microenvironment
por: Apraiz, Aintzane, et al.
Publicado: (2020)

Innate Lymphoid Cells in Skin Homeostasis and Malignancy
por: Wagner, Marek, et al.
Publicado: (2021)

Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies
por: Papafragkos, Iosif, et al.
Publicado: (2021)

Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma
por: Torka, Pallawi, et al.
Publicado: (2023)

T-cell depleted haploidentical hematopoietic cell transplantation for pediatric malignancy
por: Takahashi, Takuto, et al.
Publicado: (2022)

2'-Chlorodeoxyadenosine: evaluation of a novel predominantly lymphocyte selective agent in lymphoid malignancies.
por: Hickish, T., et al.
Publicado: (1993)

Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies
por: Maharaj, Kamira, et al.
Publicado: (2022)

Lymphoid malignancies ARNT unstoppable
por: Gardella, Kacie A., et al.
Publicado: (2016)

A Multi-Center Retrospective Review of COVID-19 Outcomes in Patients with Lymphoid Malignancy
por: Choi, Yun, et al.
Publicado: (2021)

Lymphoid Tissue Damage in HIV-1 Infection Depletes Naïve T Cells and Limits T Cell Reconstitution after Antiretroviral Therapy
por: Zeng, Ming, et al.
Publicado: (2012)

Immunoglobulin and T-cell receptor gene rearrangement analysis in malignant lymphoid neoplasms.
por: Park, C. K., et al.
Publicado: (1994)

CAR T-cell therapy in mature lymphoid malignancies: clinical opportunities and challenges
por: Narkhede, Mayur, et al.
Publicado: (2021)

Editorial: Role of the antigen receptor in the pathogenesis of B-cell lymphoid malignancies
por: Agathangelidis, Andreas, et al.
Publicado: (2023)

Anti-CD20 Depletes Meningeal B Cells but Does Not Halt the Formation of Meningeal Ectopic Lymphoid Tissue
por: Brand, Rosa Margareta, et al.
Publicado: (2021)

Murine Coronavirus Disease 2019 Lethality Is Characterized by Lymphoid Depletion Associated with Suppressed Antigen-Presenting Cell Functionality
por: Lee, Yu Jin, et al.
Publicado: (2023)

HIV-1-induced cytokines deplete homeostatic innate lymphoid cells and expand TCF7-dependent memory NK cells
por: Wang, Yetao, et al.
Publicado: (2020)

Development of venetoclax for therapy of lymphoid malignancies
por: Zhu, Huayuan, et al.
Publicado: (2017)

Histone Modifications and Their Targeting in Lymphoid Malignancies
por: Fernández-Serrano, Miranda, et al.
Publicado: (2021)

Effects of COVID-19 in lymphoid malignancies
por: Özdemir, Öner
Publicado: (2021)

The role of VipAlbumin(®) as an immunostimulatory agent for controlling homeostasis and proliferation of lymphoid cells
por: Dwijayanti, Dinia Rizqi, et al.
Publicado: (2016)

Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome and Concurrent Lymphoid Malignancy
por: Zimmerman, Zachary, et al.
Publicado: (2011)

Clinical Impact of the Immunome in Lymphoid Malignancies: The Role of Myeloid-Derived Suppressor Cells
por: Vetro, Calogero, et al.
Publicado: (2015)

Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors
por: Horton, Sarah J., et al.
Publicado: (2017)

The Role of mTOR in B Cell Lymphoid Malignancies: Biologic and Therapeutic Aspects
por: Karatrasoglou, Eleni A., et al.
Publicado: (2023)

COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma
por: Gaitzsch, Erik, et al.
Publicado: (2021)

Stromal niche communalities underscore the contribution of the matricellular protein SPARC to B-cell development and lymphoid malignancies
por: Sangaletti, Sabina, et al.
Publicado: (2014)

Novel agents and biomarkers for acute lymphoid leukemia
por: Zhao, Yanmin, et al.
Publicado: (2013)

Clinical experiences with venetoclax and other pro-apoptotic agents in lymphoid malignancies: lessons from monotherapy and chemotherapy combination
por: Lew, Thomas E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_774k1bi460shoaqhalpue1a0sg